ADC Therapeutics is a commercial-stage oncology-focused biotechnology company developing ADCs for patients with hematological malignancies & solid tumors. Our mission is to accelerate the discovery & development of antibody-drug conjugates (ADCs) for patients fighting cancerNumber of Partnerships: 10
